Fingerprint
Dive into the research topics of 'Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS
On behalf of the TECOS Study Group
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations